Potassium Chloride
Product Images NDC 68180-798

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Potassium Chloride (NDC 68180-798). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lupin Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Imgae-01 (F8b0abaa A436 43f5 9381 F3cf011bcd17 01)

Potassium Chloride Extended-Release Capsules are a medication manufactured by Lupin Pharmaceuticals, Inc. The capsules contain microencapsulated KC1 and are designed to release the active ingredient over an 8-to-10-hour period. The recommended storage temperature is between 15°C to 30°C (59°F to 86°F) and the medication should be dispensed in a tightly closed container as defined in the USP. The dosage information can be found in the accompanying prescribing information.*

FDA Label Image

Image 02 (F8b0abaa A436 43f5 9381 F3cf011bcd17 02)

NDC 68180-799-01 Potassium Chloride Extended-Release Capsules are designed to release the active ingredient microencapsulated KCI over an 8-to-10-hour period. Usual dosage and storage instructions are listed in the accompanying prescribing information. The medicine is manufactured by Lupin Pharmaceuticals, Inc. in Baltimore, Maryland, United States and Pithampur, India. The capsules contain 750mg (10 mEq K) and come in a bottle of 100 capsules. The proper method of dispensing is in a tight container as defined by the USP.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.